tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties
PremiumRatingsCautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties
3M ago
Cautious Hold Rating for Pliant Therapeutics Amidst Strategic Restructuring and Drug Development Uncertainties
Premium
Ratings
Cautious Hold Rating for Pliant Therapeutics Amidst Strategic Restructuring and Drug Development Uncertainties
3M ago
PLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Pliant Therapeutics Announces Major Workforce Reduction
PremiumCompany AnnouncementsPliant Therapeutics Announces Major Workforce Reduction
4M ago
Hold Rating on Pliant Therapeutics Amid Uncertainty and Limited Data from Early-Stage Trials
Premium
Ratings
Hold Rating on Pliant Therapeutics Amid Uncertainty and Limited Data from Early-Stage Trials
5M ago
Neutral Rating on Pliant Therapeutics Amid Early Promising Data and Uncertainties
Premium
Ratings
Neutral Rating on Pliant Therapeutics Amid Early Promising Data and Uncertainties
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
Hold Rating on Pliant Therapeutics Amid Trial Discontinuation and Safety Concerns
Premium
Ratings
Hold Rating on Pliant Therapeutics Amid Trial Discontinuation and Safety Concerns
6M ago
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
Premium
The Fly
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100